{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T01:10:09Z","timestamp":1752282609433},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-019-1011-x","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T23:08:03Z","timestamp":1558652883000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias"],"prefix":"10.1186","volume":"18","author":[{"given":"Jonas","family":"Rusnak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Behnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Schupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Taton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Bollow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reichelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Ellguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko","family":"Engelke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzair","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph A.","family":"Nienaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muharrem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambis","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Wei\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Borggrefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"1011_CR1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1186\/1471-2458-13-1135","volume":"13","author":"B Unal","year":"2013","unstructured":"Unal B, Sozmen K, Arik H, Gerceklioglu G, Altun DU, Simsek H, Doganay S, Demiral Y, Aslan O, Bennett K, et al. Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008. BMC Public Health. 2013;13:1135.","journal-title":"BMC Public Health"},{"key":"1011_CR2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/eurheartj\/ehn554","volume":"30","author":"L Bjorck","year":"2009","unstructured":"Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J. 2009;30:1046\u201356.","journal-title":"Eur Heart J"},{"key":"1011_CR3","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, et al. 2016 ESC\/EAS guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"key":"1011_CR4","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/archinte.1996.00440100050007","volume":"156","author":"R Marchioli","year":"1996","unstructured":"Marchioli R, Marfisi RM, Carinci F, Tognoni G. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Arch Intern Med. 1996;156:1158\u201372.","journal-title":"Arch Intern Med"},{"key":"1011_CR5","doi-asserted-by":"publisher","first-page":"NP1","DOI":"10.1177\/2047487316653709","volume":"23","author":"M Authors\/Task Force","year":"2016","unstructured":"Authors\/Task Force M, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint Task Force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23:NP1\u2013NP96.","journal-title":"Eur J Prev Cardiol"},{"key":"1011_CR6","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","volume":"339","author":"Long-Term Intervention with Pravastatin in Ischaemic Disease Study G","year":"1998","unstructured":"Long-Term Intervention with Pravastatin in Ischaemic Disease Study G. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339:1349\u201357.","journal-title":"N Engl J Med"},{"key":"1011_CR7","doi-asserted-by":"crossref","unstructured":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383\u20139.","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"1011_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","volume":"372","author":"L Tavazzi","year":"2008","unstructured":"Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G, Gissi HFI. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1231\u20139.","journal-title":"Lancet"},{"key":"1011_CR9","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","volume":"357","author":"J Kjekshus","year":"2007","unstructured":"Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357:2248\u201361.","journal-title":"N Engl J Med"},{"key":"1011_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jacc.2012.03.041","volume":"60","author":"J Buber","year":"2012","unstructured":"Buber J, Goldenberg I, Moss AJ, Wang PJ, McNitt S, Hall WJ, Eldar M, Barsheshet A, Shechter M. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). J Am Coll Cardiol. 2012;60:749\u201355.","journal-title":"J Am Coll Cardiol"},{"key":"1011_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1520.037X.2002.00731.x","volume":"5","author":"J De Sutter","year":"2002","unstructured":"De Sutter J, Firsovaite V, Tavernier R. Prevention of sudden death in patients with coronary artery disease: do lipid-lowering drugs play a role? Prev Cardiol. 2002;5:177\u201382.","journal-title":"Prev Cardiol"},{"key":"1011_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/eurheartj\/ehs005","volume":"33","author":"K Rahimi","year":"2012","unstructured":"Rahimi K, Majoni W, Merhi A, Emberson J. Effect of statins on ventricular tachyarrhythmia, cardiac arrest, and sudden cardiac death: a meta-analysis of published and unpublished evidence from randomized trials. Eur Heart J. 2012;33:1571\u201381.","journal-title":"Eur Heart J"},{"key":"1011_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MJT.0b013e3181e9087a","volume":"19","author":"N Wanahita","year":"2012","unstructured":"Wanahita N, Chen J, Bangalore S, Shah K, Rachko M, Coleman CI, Schweitzer P. The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis. Am J Ther. 2012;19:16\u201323.","journal-title":"Am J Ther"},{"key":"1011_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0735-1097(03)00498-4","volume":"42","author":"LB Mitchell","year":"2003","unstructured":"Mitchell LB, Powell JL, Gillis AM, Kehl V, Hallstrom AP, Investigators A. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol. 2003;42:81\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1011_CR15","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1016\/j.ijcard.2013.07.036","volume":"168","author":"YC Liao","year":"2013","unstructured":"Liao YC, Hsieh YC, Hung CY, Huang JL, Lin CH, Wang KY, Wu TJ. Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study. Int J Cardiol. 2013;168:4805\u20137.","journal-title":"Int J Cardiol"},{"key":"1011_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.amjcard.2004.10.017","volume":"95","author":"JH Chiu","year":"2005","unstructured":"Chiu JH, Abdelhadi RH, Chung MK, Gurm HS, Marrouche NF, Saliba WI, Natale A, Martin DO. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol. 2005;95:490\u20131.","journal-title":"Am J Cardiol"},{"key":"1011_CR17","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.amjcard.2007.07.015","volume":"100","author":"G Levantesi","year":"2007","unstructured":"Levantesi G, Scarano M, Marfisi R, Borrelli G, Rutjes AW, Silletta MG, Tognoni G, Marchioli R. Meta-analysis of effect of statin treatment on risk of sudden death. Am J Cardiol. 2007;100:1644\u201350.","journal-title":"Am J Cardiol"},{"key":"1011_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jacc.2005.09.053","volume":"47","author":"AK Vyas","year":"2006","unstructured":"Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, et al. Reduction in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial (MADIT)-II. J Am Coll Cardiol. 2006;47:769\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"1011_CR19","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jacc.2006.05.053","volume":"48","author":"JJ Goldberger","year":"2006","unstructured":"Goldberger JJ, Subacius H, Schaechter A, Howard A, Berger R, Shalaby A, Levine J, Kadish AH, Investigators D. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1228\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"1011_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1177\/1074248409340157","volume":"14","author":"H Desai","year":"2009","unstructured":"Desai H, Aronow WS, Tsai FS, Ahn C, Lai HM, Amin H, Gandhi K, Frishman WH, Cohen M, Sorbera C. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy. J Cardiovasc Pharmacol Ther. 2009;14:176\u20139.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1011_CR21","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"},{"key":"1011_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399\u2013424.","journal-title":"Multivariate Behav Res"},{"key":"1011_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/IJGM.S104313","volume":"9","author":"D Ferdinand","year":"2016","unstructured":"Ferdinand D, Otto M, Weiss C. Get the most from your data: a propensity score model comparison on real-life data. Int J Gen Med. 2016;9:123\u201331.","journal-title":"Int J Gen Med"},{"key":"1011_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cardfail.2007.10.013","volume":"14","author":"B Vrtovec","year":"2008","unstructured":"Vrtovec B, Okrajsek R, Golicnik A, Ferjan M, Starc V, Schlegel TT, Radovancevic B. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure. J Card Fail. 2008;14:140\u20134.","journal-title":"J Card Fail"},{"key":"1011_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2165\/11536690-000000000-00000","volume":"10","author":"A Beri","year":"2010","unstructured":"Beri A, Contractor T, Khasnis A, Thakur R. Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect? Am J Cardiovasc Drugs. 2010;10:155\u201364.","journal-title":"Am J Cardiovasc Drugs"},{"key":"1011_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","volume":"127","author":"F Violi","year":"2013","unstructured":"Violi F, Calvieri C, Ferro D, Pignatelli P. Statins as antithrombotic drugs. Circulation. 2013;127:251\u20137.","journal-title":"Circulation"},{"key":"1011_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","volume":"25","author":"A Undas","year":"2005","unstructured":"Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005;25:287\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1011_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2143\/AC.59.3.2005187","volume":"59","author":"T Tekten","year":"2004","unstructured":"Tekten T, Ceyhan C, Ercan E, Onbasili AO, Turkoglu C. The effect of atorvastatin on platelet function in patients with coronary artery disease. Acta Cardiol. 2004;59:311\u20135.","journal-title":"Acta Cardiol"},{"key":"1011_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1586\/14779072.2014.942286","volume":"12","author":"J Lewek","year":"2014","unstructured":"Lewek J, Kaczmarek K, Cygankiewicz I, Wranicz JK, Ptaszynski P. Inflammation and arrhythmias: potential mechanisms and clinical implications. Expert Rev Cardiovasc Ther. 2014;12:1077\u201385.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1011_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"MA Albert","year":"2001","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM, Investigators P. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286:64\u201370.","journal-title":"JAMA"},{"key":"1011_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1136\/hrt.2005.065771","volume":"92","author":"LM Biasucci","year":"2006","unstructured":"Biasucci LM, Giubilato G, Biondi-Zoccai G, Sanna T, Liuzzo G, Piro M, De Martino G, Ierardi C, dello Russo A, Pelargonio G, et al. C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator. Heart. 2006;92:1147\u20138.","journal-title":"Heart"},{"key":"1011_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/clc.20435","volume":"32","author":"H Abuissa","year":"2009","unstructured":"Abuissa H, O'Keefe JH, Bybee KA. Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias. Clin Cardiol. 2009;32:549\u201352.","journal-title":"Clin Cardiol"},{"key":"1011_CR33","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.hrthm.2017.05.026","volume":"14","author":"H Jin","year":"2017","unstructured":"Jin H, Welzig CM, Aronovitz M, Noubary F, Blanton R, Wang B, Rajab M, Albano A, Link MS, Noujaim SF, et al. QRS\/T-wave and calcium alternans in a type I diabetic mouse model for spontaneous postmyocardial infarction ventricular tachycardia: a mechanism for the antiarrhythmic effect of statins. Heart Rhythm. 2017;14:1406\u201316.","journal-title":"Heart Rhythm"},{"key":"1011_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0735-1097(00)00787-7","volume":"36","author":"J De Sutter","year":"2000","unstructured":"De Sutter J, Tavernier R, De Buyzere M, Jordaens L, De Backer G. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol. 2000;36:766\u201372.","journal-title":"J Am Coll Cardiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-1011-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1011-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T23:09:20Z","timestamp":1590188960000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1011-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-1011-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The registry was carried out according to the principles of the declaration of Helsinki and was approved by the medical ethics committee II of the Medical Faculty Mannheim, University of Heidelberg, Germany.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"119"}}